None
Quote | Hoth Therapeutics Inc. (NYSE:HOTH)
Last: | $ |
---|---|
Change Percent: | -0.21% |
Open: | $6.36 |
Close: | $4.9494 |
High: | $7.20 |
Low: | $4.51 |
Volume: | 1,039,797 |
Last Trade Date Time: | 02/12/2020 04:40:19 pm |
News | Hoth Therapeutics Inc. (NYSE:HOTH)
2024-04-11 16:24:38 ET More on Hoth Therapeutics Hoth stock rallies 24% on preclinical Alzheimer's data Hoth stock jumps on FDA approval of study expansion for HT-001 Seeking Alpha’s Quant Rating on Hoth Therapeutics Historical earnings data for Hoth T...
China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...
Message Board Posts | Hoth Therapeutics Inc. (NYSE:HOTH)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $HOTH Lod1.56=LL How low does it go? | znewcar1 | investorshangout | 04/26/2023 1:57:36 PM |
Hoth Therapeutics and Algorithm Sciences Execute Letter of | subslover | investorshub | 04/26/2023 1:06:54 PM |
.42 spike up just now | PennyPusher786 | investorshub | 03/31/2023 3:18:24 PM |
That looks nice I have no idea what | hawkshaw812 | investorshub | 02/23/2023 3:20:21 AM |
$HOTH........................................https://stockcharts.com/h-sc/ui?s=HO | glenn1919 | investorshub | 02/22/2023 3:20:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NYSE Market:
China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds PR Newswire NEW YORK , March 27, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a defin...
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment PR Newswire Merveille.ai Files Patent for Obesity Treatment, Begins Preparatory Steps for Clinical Trials, Joins Nvidia Developer Program NEW YORK , Ma...